FDA proposes voluntary program to qualify medtech development tools

11/21/2013 | Clinica (subscription required)

The FDA has issued draft guidance outlining its proposal to launch a voluntary program for the qualification of medical device development tools, which are used in assessing how a device functions. The proposal, which is up for comment through Feb. 12, aims to make such instruments available to more sponsors to allow faster development of medical technologies.

View Full Article in:

Clinica (subscription required)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Meridian Health Plan
Detroit, MI